Asep Medical Holdings Inc
SEPSF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -538% | – | – | – |
| R&D Expenses | $1 | $1 | $0 | $0 |
| G&A Expenses | $4 | $3 | $2 | $0 |
| SG&A Expenses | $4 | $3 | $2 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $3 | -$0 | -$0 | $0 |
| Operating Expenses | $8 | $5 | $2 | $0 |
| Operating Income | -$8 | -$5 | -$2 | -$0 |
| % Margin | -36,524.4% | – | – | – |
| Other Income/Exp. Net | -$2 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$9 | -$6 | -$2 | -$0 |
| Tax Expense | $0 | -$0 | -$0 | $0 |
| Net Income | -$8 | -$5 | -$2 | -$0 |
| % Margin | -38,918.3% | – | – | – |
| EPS | -0.13 | -0.081 | -0.039 | -0.002 |
| % Growth | -61.5% | -105.4% | -1,963.2% | – |
| EPS Diluted | -0.13 | -0.081 | -0.039 | -0.002 |
| Weighted Avg Shares Out | 62 | 56 | 56 | 15 |
| Weighted Avg Shares Out Dil | 62 | 56 | 56 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$8 | -$3 | -$2 | $0 |
| % Margin | -38,486.2% | – | – | – |